# FDA Inspection 771926 - Rpk Pharmaceuticals Inc - March 08, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/e780fe8e-5ff4-4a18-91b8-4e47c32f5d1a
Source feed: FDA_Inspections

> FDA Inspection 771926 for Rpk Pharmaceuticals Inc on March 08, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 771926
- Company Name: Rpk Pharmaceuticals Inc
- Inspection Date: 2012-03-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1155217 - 2021-10-14](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/29b04edb-3611-4cb7-836f-566da8a56f09)
- [FDA Inspection 1081636 - 2019-02-28](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/32fb44df-9b7a-445b-9b2e-fd6c48437eec)
- [FDA Inspection 660576 - 2010-04-09](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/e0cce943-b8eb-4be0-879e-6b807473056f)
- [FDA Inspection 603965 - 2009-08-07](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/8ee254b1-ebe4-49cc-9c2b-56927d1355d4)

Company: https://www.globalkeysolutions.net/companies/rpk-pharmaceuticals-inc/4fcc57aa-1dbd-44d8-859b-3754c50751af

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c